| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $195.2M | +10.5% |
| Cost of Revenue | $176.8M | +31.1% |
| Gross Profit | $18.4M | -55.9% |
| R&D Expense | $15.8M | +21.5% |
| SG&A Expense | $16.2M | +16.1% |
| Operating Income | -$18.4M | -309.8% |
| Interest Expense | $1.1M | -4.0% |
| Pre-tax Income | -$11.1M | -199.9% |
| Income Tax | -$185K | -111.8% |
| Net Income | -$9.4M | -179.5% |
| EPS (Basic) | -$0.10 | -176.9% |
| EPS (Diluted) | -$0.10 | -176.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.3M | +23.4% |
| Short-term Investments | $4.2M | +0.0% |
| Accounts Receivable | $38.4M | +16.6% |
| Inventory | $50.6M | +121.4% |
| Current Assets | $180.6M | +27.8% |
| Total Assets | $426.2M | +41.0% |
| Current Liabilities | $299.8M | +74.6% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $48.6M | +22.3% |
| Capital Expenditures | $44.7M | +159.8% |
| Investing Cash Flow | -$45.7M | -95.1% |
| Financing Cash Flow | $8.0M | +168.5% |
| Free Cash Flow | $3.9M | -82.7% |
| $4.1M |
| — |
| Total Liabilities | $316.7M | +73.9% |
| Stockholders' Equity | $112.7M | -7.4% |